GlobeNewswire 2023-10-17 Cellectar Biosciences Expands Commercialization Leadership Team Ahead of Pivotal Data for Iopofosine...
GlobeNewswire 2023-10-16 Zymeworks Announces New Director Nominee
GlobeNewswire 2022-03-22 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beigene, Ltd. - ...
GlobeNewswire 2022-03-10 Gritstone Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Corporate Up...
GlobeNewswire 2022-03-10 Assembly Biosciences Reports Fourth Quarter and Year End 2021 Financial Results and Recent Highlight...
GlobeNewswire 2022-03-10 JD.com Announces Fourth Quarter and Full Year 2021 Results
GlobeNewswire 2022-03-09 Jane Huang, M.D., Joins Prelude Therapeutics as President and Chief Medical Officer
GlobeNewswire 2022-03-03 HUTCHMED Reports 2021 Full Year Results and Provides Business Updates
GlobeNewswire 2022-03-01 HUTCHMED Receives Approval to Commercialize ELUNATE® in Macau
GlobeNewswire 2022-02-24 SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Busi...
GlobeNewswire 2022-01-31 ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data
GlobeNewswire 2022-01-25 IMX-110 + anti-PD-1 Combination Produced Extended Median Survival in Genetic Pancreatic Cancer Mouse...
GlobeNewswire 2022-01-19 HUTCHMED Highlights Fruquintinib Clinical Data to be Presented at the 2022 ASCO Gastrointestinal Can...
GlobeNewswire 2021-12-17 Gritstone Announces Changes to Its Board of Directors
GlobeNewswire 2021-12-10 HUTCHMED Highlights Surufatinib and Toripalimab Combination Clinical Data being Presented at the ESM...
GlobeNewswire 2021-12-06 HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metas...
GlobeNewswire 2021-12-03 HUTCHMED Announces Agreement with NHSA for Continued Inclusion of ELUNATE® and Addition of SULANDA® ...
GlobeNewswire 2021-11-04 Assembly Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
GlobeNewswire 2021-11-04 SpringWorks Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
GlobeNewswire 2021-09-21 HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA® in Combination with TUOYI® in the Treat...
GlobeNewswire 2021-09-20 HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendo...
GlobeNewswire 2021-08-26 HUTCHMED Initiates a Phase Ib/II Trial of Fruquintinib in Combination with Tislelizumab in Advanced ...
GlobeNewswire 2021-08-12 Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Str...
GlobeNewswire 2021-08-05 Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview
GlobeNewswire 2021-08-04 SpringWorks Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlight...